2010•Trends in Urology Gynaecology & Sexual HealthRequires access

Androgen deprivation therapy for prostate cancer and its complications

A. Pope, Paul David Abel

Open publisher page 4 citations

Abstract

Abstract This article focuses on the hormonal treatment of prostate cancer by the reduction of androgen activity. The authors outline the under‐recognised complications that can be caused by the castration effect of androgen deprivation therapy. Copyright © 2010 Wiley Interface Ltd

About this research paper

What this paper is about

Abstract This article focuses on the hormonal treatment of prostate cancer by the reduction of androgen activity. The authors outline the under‐recognised complications that can be caused by the castration effect of androgen deprivation therapy. Copyright © 2010 Wiley Interface Ltd

Why it matters

OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Abstract This article focuses on the hormonal treatment of prostate cancer by the reduction of androgen activity. The authors outline the under‐recognised complications that can be caused by the castration effect of androgen deprivation therapy. Copyright © 2010 Wiley Interface Ltd

Key concepts: Prostate cancer, Androgen deprivation therapy, Medicine, Androgen, Castration, Hormonal therapy, Oncology, Cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
Androgen deprivation therapy for prostate cancer and its complications — Research Paper | ScholarLens